93 results
DEFA14A
INZY
Inozyme Pharma Inc
26 Apr 24
Additional proxy soliciting materials
4:40pm
independent registered public accounting firm for the fiscal year ending December 31, 2024. Note: The proxies are authorized to vote, in their discretion
S-8
INZY
Inozyme Pharma Inc
12 Mar 24
Registration of securities for employees
8:40am
& Young LLP, independent registered public accounting firm
Power of Attorney (included on the signature pages of this registration statement)
2020
S-8
EX-23.2
INZY
Inozyme Pharma Inc
12 Mar 24
Registration of securities for employees
8:40am
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
8-K
EX-1.1
y1e9s5v9ncqwga5alzw
28 Jul 23
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
5:19pm
424B5
zv2ds0wg6st6morcc
28 Jul 23
Prospectus supplement for primary offering
5:17pm
424B5
ynb48n4hdi
27 Jul 23
Prospectus supplement for primary offering
5:28pm
8-K
EX-3.1
6b9gtz
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:36pm
8-K
oypuy5
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:36pm
DEFA14A
xx3u6osx h9
27 Apr 23
Additional proxy soliciting materials
8:36am